Milind Singh

Milind Singh is a strategy consultant at Ambit Inc., specializing in providing strategic insights for biopharma clients in the rare and specialty disease sectors. They hold a Ph.D. in Cell Biology from Yale University, where their research focused on neuronal metabolic adaptation. With over nine years of experience in research and consulting, Milind has worked in various biotech roles, including conducting due diligence at Orange Grove Bio and evaluating pipeline strategies at Allyx Therapeutics. They are also passionate about scientific communication, having mentored peers and authored publications throughout their career.